Cargando…
The Immunology of Hepatocellular Carcinoma
Liver cancer is the third leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver. Liver resection or transplantation offer the only potentially curative options for HCC; however, many patients are not candidates for surgical re...
Autores principales: | Lawal, Gbemisola, Xiao, Yao, Rahnemai-Azar, Amir A., Tsilimigras, Diamantis I., Kuang, Ming, Bakopoulos, Anargyros, Pawlik, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538643/ https://www.ncbi.nlm.nih.gov/pubmed/34696292 http://dx.doi.org/10.3390/vaccines9101184 |
Ejemplares similares
-
Recurrent Hepatocellular Carcinoma: Patterns, Detection, Staging and Treatment
por: Papaconstantinou, Dimitrios, et al.
Publicado: (2022) -
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Machairas, Nikolaos, et al.
Publicado: (2022) -
Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Tsilimigras, Diamantis I., et al.
Publicado: (2020) -
Synchronous resection of esophageal cancer and other organ malignancies: A systematic review
por: Papaconstantinou, Dimitrios, et al.
Publicado: (2019) -
Meta-Analysis of Repeat Hepatectomy versus Radiofrequency Ablation for Recurrence of Hepatocellular Carcinoma
por: Machairas, Nikolaos, et al.
Publicado: (2022)